JPRN-UMIN000051748已完成Unknown
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK) - A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Subjects who have regular hard exercise. (2) Heavy drinker of alcohol and heavy smoker (3) Subjects who use of products affecting the data of this study, such as food for specified health use, and food with function claims. (4) Subjects who continuously take medicines. (5) Subjects who are participating in other study or planning to participate or participated within the past 4 weeks. (6) Subjects who are: a) heart, liver, or kidney disease (including complications of other diseases) b) undergoing treatment for or have a history of cardiovascular disease c) diabetes d) allergic to test foods e) undergoing treatment for or have a history of serious diseases such as cancer or tuberculosis f) having history of comorbidities in the gastrointestinal tract (excluding a history of cecum) (7) Others who are judged inappropriate for participant by the investigator
研究者
相似试验
已完成
不适用
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cartdiac angiographyHeart FailureJPRN-UMIN000009924Showa University Northern Hospital100
已完成
不适用
A study to investigate the efficacy and dose response of Euglena by questionnaires for a measure of the subjective well-beingHealthy individualsJPRN-UMIN000037200everage Brain Inc.210
已完成
4 期
Intranasal ketamine for moderate to severe pain in children- a dose finding study.acute painmusculoskeletal injuryAnaesthesiology - Pain managementInjuries and Accidents - Other injuries and accidentsACTRN12612000012875Southern Health60
已完成
2 期
The Study of Dose Response Relationship Evaluation of AryoSeven in Hemophilia PatientsCondition 1: Congenital Hemophilia A with inhibitors. Condition 2: Congenital Hemophilia B with inhibitors.Hereditary factor VIII deficiencyHereditary factor IX deficiencyIRCT20161202031193N3AryoGen Pharmed12
已完成
不适用
Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patientsOveractive bladderJPRN-UMIN000012640Clinical Research Support Center Kyushu100